Benzinga - by Benzinga Insights, Benzinga Staff Writer. Gilead Sciences's (NYSE:GILD) short percent of float has risen % since its last report. The company recently reported that it has million shares sold short, which is % of all regular shares that are available for [HOST] on its trading Required rate of return on Gilead Sciences Inc. common stock 3: r GILD: %: 1 Unweighted average of bid yields on all outstanding fixed-coupon U.S. Treasury bonds neither due or callable in less than 10 years (risk-free rate of return proxy) FOSTER CITY, Calif (BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the first quarter of “Gilead’s track record of strong commercial and clinical execution continued through the first quarter of A 15% year-over-year revenue increase reflects Gilead Sciences is a biopharmaceutical company that researches, develops, and sells therapies for treating HIV, hepatitis B, hepatitis C, and certain cancers. In October , Gilead's Veklury Get the latest Gilead Sciences, Inc. (GILD) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions
Gilead Sciences, Inc. (GILD) Stock Price & News - Google
Gilead Sciences (GILD) closed the latest trading day at $, indicating a +% change from the previous session's end. The stock outperformed the S&P , which registered a daily gain of 0 Interactive stock price chart for Gilead Sciences, Inc. (GILD) with real-time updates, full price history, technical analysis and more Q2 EPS Estimate Trends. Current. $ 1 Month Ago. $ 3 Months Ago. $ Gilead Sciences Inc. analyst estimates, including GILD earnings per share estimates and analyst recommendations Get the latest Gilead Sciences, Inc. (1GILD) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions
Gilead Sciences Share Price. 0QYQ - Stock Quote, Charts, Trade …
Gilead Sciences Inc (GILD) Common Stock USD Gilead Sciences Inc (GILD) Sell: $ Buy: $ $ (%) NASDAQ: %. Prices delayed by at least 15 minutes | Turn on streaming prices Gilead Sciences (GILD%) says that a "complex and criminal enterprise" was distributing counterfeit versions of its HIV drugs through the U.S. supply chain, The Wall Street Journal reports By the numbers, Gilead Sciences stock rose 1,% between February and August , when it traded near all-time highs. Today, the healthcare giant is down about 41% from record levels